Skip to main content
DAWN
NASDAQ Life Sciences

赛维尔以25亿美元收购Day One Biopharma，每股21.50美元

feedReported by Reuters
Sentiment info
Positive
Importance info
10
Price
$12.75
Mkt Cap
$1.351B
52W Low
$5.635
52W High
$13.2
Market data snapshot near publication time

summarizeSummary

赛维尔宣布意向以每股21.50美元的价格收购Day One Biopharmaceuticals，将公司的总股本价值定为25亿美元。这代表着对Day One当前交易价格12.75美元的巨大溢价。这一最终收购是在Day One经历了积极的势头之后，包括2025年第四季度和全年财务结果强劲以及其主打药物OJEMDA获得EMA积极意见之后进行的。该收购为股东带来立即且显著的回报，从根本上改变了DAWN的投资论点。交易者现在将关注交易的完成过程和任何潜在的监管批准。

在该公告发布时，DAWN的交易价格为$12.75，交易所为NASDAQ，所属行业为Life Sciences，市值约为$13.5亿。 52周交易区间为$5.64至$13.20。 这则新闻被评估为积极市场情绪，重要性评分为10/10。 来源：Reuters。

show_chartPrice Chart

Share this article

Copied!

feed DAWN - Latest Insights

DAWN
Apr 23, 2026, 8:57 AM EDT
Filing Type: POSASR
Importance Score:
7
Day One Biopharmaceuticals Deregisters Securities Following Servier Merger Completion
Sentiment: Neutral
View Wiseek Article
DAWN
Apr 23, 2026, 8:55 AM EDT
Filing Type: POSASR
Importance Score:
7
Day One Biopharmaceuticals Deregisters Unsold Securities Following Servier Acquisition
Sentiment: Neutral
View Wiseek Article
DAWN
Apr 23, 2026, 8:54 AM EDT
Filing Type: 8-K
Importance Score:
10
Day One Biopharmaceuticals Completes $2.5B Acquisition by Servier, Delists from Nasdaq
Sentiment: Neutral
View Wiseek Article
DAWN
Apr 23, 2026, 8:39 AM EDT
Filing Type: SC 14D9/A
Importance Score:
10
Day One Biopharmaceuticals Confirms Merger Completion, Delisting from Nasdaq
Sentiment: Neutral
View Wiseek Article
DAWN
Apr 23, 2026, 8:31 AM EDT
Filing Type: SC TO-T/A
Importance Score:
10
Servier Completes Acquisition of Day One Biopharmaceuticals; Shares Delisted
Sentiment: Positive
View Wiseek Article
DAWN
Apr 23, 2026, 8:30 AM EDT
Source: Dow Jones Newswires
Importance Score:
8
Servier Completes $2.5 Billion Acquisition of Day One Biopharmaceuticals
Sentiment: Positive
View Wiseek Article
DAWN
Apr 17, 2026, 4:00 PM EDT
Filing Type: 10-K/A
Importance Score:
7
Day One Biopharmaceuticals Files Amended 10-K, Details Executive Compensation and Ownership Amidst Servier Acquisition
Sentiment: Neutral
View Wiseek Article
DAWN
Apr 14, 2026, 6:03 AM EDT
Filing Type: SC 14D9/A
Importance Score:
8
Day One Biopharmaceuticals Amends Tender Offer Statement with Shareholder Lawsuits and Updated Financial Projections
Sentiment: Neutral
View Wiseek Article
DAWN
Apr 14, 2026, 6:02 AM EDT
Filing Type: SC TO-T/A
Importance Score:
8
Day One Biopharmaceuticals Discloses Shareholder Lawsuits Challenging Servier Acquisition
Sentiment: Negative
View Wiseek Article
DAWN
Apr 13, 2026, 5:06 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
8
Major Shareholder Tenders All Shares into Servier Acquisition Offer
Sentiment: Positive
View Wiseek Article